KP Tissue Inc. (TSE:KPT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$11.88 and traded as high as C$12.80. KP Tissue shares last traded at C$12.75, with a volume of 5,022 shares trading hands.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on KPT. TD lifted their target price on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Desjardins increased their price target on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a "hold" rating in a research report on Friday, May 15th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of C$12.12.
Check Out Our Latest Stock Analysis on KP Tissue
KP Tissue Price Performance
The company has a market cap of C$127.86 million, a PE ratio of 14.49, a P/E/G ratio of -0.88 and a beta of 0.53. The firm has a 50-day simple moving average of C$13.03 and a two-hundred day simple moving average of C$11.88.
KP Tissue (TSE:KPT - Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. Equities research analysts forecast that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 15th were paid a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.84 annualized dividend and a yield of 6.6%. KP Tissue's payout ratio is presently 85.23%.
Insider Transactions at KP Tissue
In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the company's stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the transaction, the director directly owned 15,712 shares in the company, valued at approximately C$208,969.60. This represents a 18.93% decrease in their position. In the last 90 days, insiders have sold 6,668 shares of company stock valued at $87,644. 0.14% of the stock is currently owned by corporate insiders.
About KP Tissue
(
Get Free Report)
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.